BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9020185)

  • 1. Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL.
    Ono Y; Fukuhara N; Yoshie O
    J Biol Chem; 1997 Feb; 272(7):4576-81. PubMed ID: 9020185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3.
    Ono Y; Fukuhara N; Yoshie O
    Mol Cell Biol; 1998 Dec; 18(12):6939-50. PubMed ID: 9819382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a TAL1 target gene reveals a positive role for the LIM domain-binding protein Ldb1 in erythroid gene expression and differentiation.
    Xu Z; Huang S; Chang LS; Agulnick AD; Brandt SJ
    Mol Cell Biol; 2003 Nov; 23(21):7585-99. PubMed ID: 14560005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCL assembles a multifactorial complex that determines glycophorin A expression.
    Lahlil R; Lécuyer E; Herblot S; Hoang T
    Mol Cell Biol; 2004 Feb; 24(4):1439-52. PubMed ID: 14749362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth inhibition and apoptosis due to restoration of E2A activity in T cell acute lymphoblastic leukemia cells.
    Park ST; Nolan GP; Sun XH
    J Exp Med; 1999 Feb; 189(3):501-8. PubMed ID: 9927512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pentamer transcriptional complex including tal-1 and retinoblastoma protein downmodulates c-kit expression in normal erythroblasts.
    Vitelli L; Condorelli G; Lulli V; Hoang T; Luchetti L; Croce CM; Peschle C
    Mol Cell Biol; 2000 Jul; 20(14):5330-42. PubMed ID: 10866689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.
    Li Y; Deng C; Hu X; Patel B; Fu X; Qiu Y; Brand M; Zhao K; Huang S
    Oncogene; 2012 Nov; 31(48):5007-18. PubMed ID: 22310283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1.
    Lin YW; Deveney R; Barbara M; Iscove NN; Nimer SD; Slape C; Aplan PD
    Cancer Res; 2005 Aug; 65(16):7151-8. PubMed ID: 16103065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory mechanisms and context-dependent roles of TAL1 in T-cell acute lymphoblastic leukemia.
    Ong JZL; Tan TK; Wang L; Tan SH; Sanda T
    Haematologica; 2024 May; 109(5):1359-1372. PubMed ID: 37855064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of quiescent thymic progenitors in TAL/LMO2-induced T-ALL chemotolerance.
    O'Connor KW; Kishimoto K; Kuzma IO; Wagner KP; Selway JS; Roderick JE; Karna KK; Gallagher KM; Hu K; Liu H; Li R; Brehm MA; Zhu LJ; Curtis DJ; Tremblay CS; Kelliher MA
    Leukemia; 2024 May; 38(5):951-962. PubMed ID: 38553571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative network analysis reveals USP7 haploinsufficiency inhibits E-protein activity in pediatric T-lineage acute lymphoblastic leukemia (T-ALL).
    Shaw TI; Dong L; Tian L; Qian C; Liu Y; Ju B; High A; Kavdia K; Pagala VR; Shaner B; Pei D; Easton J; Janke LJ; Porter SN; Ma X; Cheng C; Pruett-Miller SM; Choi J; Yu J; Peng J; Gu W; Look AT; Downing JR; Zhang J
    Sci Rep; 2021 Mar; 11(1):5154. PubMed ID: 33664368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglia recapitulate a hematopoietic master regulator network in the aging human frontal cortex.
    Wehrspaun CC; Haerty W; Ponting CP
    Neurobiol Aging; 2015 Aug; 36(8):2443.e9-2443.e20. PubMed ID: 26002684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel TAL1/miR-149* axis accelerates tumor growth of human T cell acute lymphoblastic leukemia.
    Zhao Y; Li H; Li Y; Chen X; Fan S
    Int J Clin Exp Pathol; 2018; 11(8):4026-4034. PubMed ID: 31949792
    [No Abstract]   [Full Text] [Related]  

  • 14. Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia.
    Tan TK; Zhang C; Sanda T
    Int J Hematol; 2019 Jan; 109(1):5-17. PubMed ID: 30145780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LMO2 is required for TAL1 DNA binding activity and initiation of definitive haematopoiesis at the haemangioblast stage.
    Stanulovic VS; Cauchy P; Assi SA; Hoogenkamp M
    Nucleic Acids Res; 2017 Sep; 45(17):9874-9888. PubMed ID: 28973433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-146b negatively regulates migration and delays progression of T-cell acute lymphoblastic leukemia.
    Correia NC; Fragoso R; Carvalho T; Enguita FJ; Barata JT
    Sci Rep; 2016 Aug; 6():31894. PubMed ID: 27550837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem Cell Leukemia: how a TALented actor can go awry on the hematopoietic stage.
    Correia NC; Arcangeli ML; Pflumio F; Barata JT
    Leukemia; 2016 Oct; 30(10):1968-1978. PubMed ID: 27443261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LMO2 at 25 years: a paradigm of chromosomal translocation proteins.
    Chambers J; Rabbitts TH
    Open Biol; 2015 Jun; 5(6):150062. PubMed ID: 26108219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemia.
    Oram SH; Thoms J; Sive JI; Calero-Nieto FJ; Kinston SJ; Schütte J; Knezevic K; Lock RB; Pimanda JE; Göttgens B
    Leukemia; 2013 Jun; 27(6):1348-57. PubMed ID: 23302769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma.
    Cubedo E; Gentles AJ; Huang C; Natkunam Y; Bhatt S; Lu X; Jiang X; Romero-Camarero I; Freud A; Zhao S; Bacchi CE; Martínez-Climent JA; Sánchez-García I; Melnick A; Lossos IS
    Blood; 2012 Jun; 119(23):5478-91. PubMed ID: 22517897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.